Dermata Total Assets from 2010 to 2024

DRMA Stock  USD 0.39  0.01  2.50%   
Dermata Therapeutics' Total Assets are increasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 6.4 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
M
Current Value
6.4 M
Quarterly Volatility
3.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dermata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermata main balance sheet or income statement drivers, such as Net Interest Income of 213.6 K, Depreciation And Amortization of 7 K or Interest Expense of 111.4 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Price Book Value Ratio of 0.29. Dermata financial statements analysis is a perfect complement when working with Dermata Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Dermata Therapeutics Technical models . Check out the analysis of Dermata Therapeutics Correlation against competitors.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

Latest Dermata Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Dermata Therapeutics over the last few years. Total assets refers to the total amount of Dermata Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dermata Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Dermata Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dermata Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 7.98 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Dermata Total Assets Regression Statistics

Arithmetic Mean3,615,905
Geometric Mean2,733,157
Coefficient Of Variation85.96
Mean Deviation2,468,196
Median2,065,803
Standard Deviation3,108,060
Sample Variance9.7T
Range11M
R-Value0.64
Mean Square Error6.2T
R-Squared0.41
Significance0.01
Slope443,777
Total Sum of Squares135.2T

Dermata Total Assets History

20246.4 M
2023M
20226.9 M
202111.6 M
2020605.5 K

About Dermata Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dermata Therapeutics income statement, its balance sheet, and the statement of cash flows. Dermata Therapeutics investors use historical funamental indicators, such as Dermata Therapeutics's Total Assets, to determine how well the company is positioned to perform in the future. Although Dermata Therapeutics investors may use each financial statement separately, they are all related. The changes in Dermata Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dermata Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dermata Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dermata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Total AssetsM6.4 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dermata Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dermata Therapeutics' short interest history, or implied volatility extrapolated from Dermata Therapeutics options trading.

Pair Trading with Dermata Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermata Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Dermata Stock

  0.73MBRX Moleculin Biotech Upward RallyPairCorr
  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Dermata Stock

  0.77DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.73MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.72MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.68MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.63EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Dermata Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermata Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermata Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermata Therapeutics to buy it.
The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermata Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermata Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermata Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dermata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermata Therapeutics Stock:
Check out the analysis of Dermata Therapeutics Correlation against competitors.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Dermata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.67)
Return On Assets
(0.67)
Return On Equity
(1.26)
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.